-
1
-
-
0034983045
-
Diagnostic criteria and classification of mastocytosis: a consensus proposal
-
Valent P, Horny HP, Escribano L et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res 2001; 25(7): 603-625.
-
(2001)
Leuk Res
, vol.25
, Issue.7
, pp. 603-625
-
-
Valent, P.1
Horny, H.P.2
Escribano, L.3
-
2
-
-
0003053208
-
Mastocytosis (mast cell disease)
-
Jaffe ES, Harris NL, Stein H et al. (eds), World Health Organization (WHO) Classification of Tumours. France: IARC Press Lyon
-
Valent P, Horny H-P, Li CY et al. Mastocytosis (mast cell disease). In Jaffe ES, Harris NL, Stein H et al. (eds), World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. France: IARC Press Lyon, 2001; 291-302.
-
(2001)
Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues
, pp. 291-302
-
-
Valent, P.1
Horny, H.-P.2
Li, C.Y.3
-
3
-
-
61549132662
-
Mastocytosis (mast cell disease)
-
Swerdlow SH, Campo E, Harris NL et al. (eds), World Health Organization (WHO) Classification of Tumours. Lyon, France: IARC Press
-
Horny HP, Akin C, Metcalfe DD et al. Mastocytosis (mast cell disease). In Swerdlow SH, Campo E, Harris NL et al. (eds), World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press, 2008; 54-63.
-
(2008)
Pathology & Genetics, Tumours of Haematopoietic and Lymphoid Tissues
, pp. 54-63
-
-
Horny, H.P.1
Akin, C.2
Metcalfe, D.D.3
-
4
-
-
0141506139
-
Mast cell proliferative disorders: current view on variants recognized by the World Health Organization
-
Valent P, Akin C, Sperr WR et al. Mast cell proliferative disorders: current view on variants recognized by the World Health Organization. Hematol Oncol Clin North Am 2003; 17(5): 1227-1241.
-
(2003)
Hematol Oncol Clin North Am
, vol.17
, Issue.5
, pp. 1227-1241
-
-
Valent, P.1
Akin, C.2
Sperr, W.R.3
-
5
-
-
0034983239
-
Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis
-
Sperr WR, Escribano L, Jordan JH et al. Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis. Leuk Res 2001; 25(7): 529-536.
-
(2001)
Leuk Res
, vol.25
, Issue.7
, pp. 529-536
-
-
Sperr, W.R.1
Escribano, L.2
Jordan, J.H.3
-
6
-
-
67651120132
-
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors
-
Lim KH, Tefferi A, Lasho TL et al. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009; 113(23): 5727-5736.
-
(2009)
Blood
, vol.113
, Issue.23
, pp. 5727-5736
-
-
Lim, K.H.1
Tefferi, A.2
Lasho, T.L.3
-
7
-
-
69349102308
-
Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients
-
Escribano L, Alvarez-Twose I, Sánchez-Muñoz L et al. Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients. J Allergy Clin Immunol 2009; 124(3): 514-521.
-
(2009)
J Allergy Clin Immunol
, vol.124
, Issue.3
, pp. 514-521
-
-
Escribano, L.1
Alvarez-Twose, I.2
Sánchez-Muñoz, L.3
-
8
-
-
70449706224
-
Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies
-
Pardanani A, Lim KH, Lasho TL et al. Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. Blood 2009; 114(18): 3769-3772.
-
(2009)
Blood
, vol.114
, Issue.18
, pp. 3769-3772
-
-
Pardanani, A.1
Lim, K.H.2
Lasho, T.L.3
-
9
-
-
0022969412
-
Mast cell leukemia: report of a case and review of the literature
-
Travis WD, Li CY, Hoagland HC et al. Mast cell leukemia: report of a case and review of the literature. Mayo Clinic Proc 1986; 61(12): 957-966.
-
(1986)
Mayo Clinic Proc
, vol.61
, Issue.12
, pp. 957-966
-
-
Travis, W.D.1
Li, C.Y.2
Hoagland, H.C.3
-
10
-
-
0022485244
-
Mast cell leukaemia: evidence for bone marrow origin of the pathologic clone
-
Dalton R, Chan L, Batten E et al. Mast cell leukaemia: evidence for bone marrow origin of the pathologic clone. Br J Haematol 1986; 64(2): 397-406.
-
(1986)
Br J Haematol
, vol.64
, Issue.2
, pp. 397-406
-
-
Dalton, R.1
Chan, L.2
Batten, E.3
-
11
-
-
0345772088
-
Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria
-
Valent P, Akin C, Sperr WR et al. Aggressive systemic mastocytosis and related mast cell disorders: current treatment options and proposed response criteria. Leuk Res 2003; 27(7): 635-641.
-
(2003)
Leuk Res
, vol.27
, Issue.7
, pp. 635-641
-
-
Valent, P.1
Akin, C.2
Sperr, W.R.3
-
13
-
-
9044235583
-
A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone
-
Baghestanian M, Bankl HC, Sillaber C et al. A case of malignant mastocytosis with circulating mast cell precursors: biologic and phenotypic characterization of the malignant clone. Leukemia 1996; 10(1): 159-166.
-
(1996)
Leukemia
, vol.10
, Issue.1
, pp. 159-166
-
-
Baghestanian, M.1
Bankl, H.C.2
Sillaber, C.3
-
14
-
-
0034981905
-
Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis
-
Escribano L, Díaz-Agustín B, Bellas C et al. Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis. Leuk Res 2001; 25(7): 563-570.
-
(2001)
Leuk Res
, vol.25
, Issue.7
, pp. 563-570
-
-
Escribano, L.1
Díaz-Agustín, B.2
Bellas, C.3
-
15
-
-
77949268924
-
Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes
-
Teodosio C, García-Montero AC, Jara-Acevedo M et al. Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. J Allergy Clin Immunol 2010; 125(3): 719-726.
-
(2010)
J Allergy Clin Immunol
, vol.125
, Issue.3
, pp. 719-726
-
-
Teodosio, C.1
García-Montero, A.C.2
Jara-Acevedo, M.3
-
16
-
-
84875759168
-
Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis
-
Teodosio C, García-Montero AC, Jara-Acevedo M et al. Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis. J Allergy Clin Immunol 2013; 131(4): 1213-1224.
-
(2013)
J Allergy Clin Immunol
, vol.131
, Issue.4
, pp. 1213-1224
-
-
Teodosio, C.1
García-Montero, A.C.2
Jara-Acevedo, M.3
-
17
-
-
0032523149
-
Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications
-
Escribano L, Orfao A, Díaz-Agustin B et al. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood 1998; 91(8): 2731-2736.
-
(1998)
Blood
, vol.91
, Issue.8
, pp. 2731-2736
-
-
Escribano, L.1
Orfao, A.2
Díaz-Agustin, B.3
-
18
-
-
0030900209
-
Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia
-
Escribano L, Orfao A, Villarrubia J et al. Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia. Cytometry 1997; 30(2): 98-102.
-
(1997)
Cytometry
, vol.30
, Issue.2
, pp. 98-102
-
-
Escribano, L.1
Orfao, A.2
Villarrubia, J.3
-
19
-
-
79953331926
-
Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis
-
Sotlar K, Cerny-Reiterer S, Petat-Dutter K et al. Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis. Mod Pathol 2011; 24(4): 585-595.
-
(2011)
Mod Pathol
, vol.24
, Issue.4
, pp. 585-595
-
-
Sotlar, K.1
Cerny-Reiterer, S.2
Petat-Dutter, K.3
-
20
-
-
79955059422
-
Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms
-
Valent P, Sotlar K, Horny HP. Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: a differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms. Leuk Lymphoma 2011; 52 (5): 740-744.
-
(2011)
Leuk Lymphoma
, vol.52
, Issue.5
, pp. 740-744
-
-
Valent, P.1
Sotlar, K.2
Horny, H.P.3
-
21
-
-
84887816251
-
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis
-
Morgado JM, Perbellini O, Johnson RC et al. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis. Histopathology 2013; 63: 780-787.
-
(2013)
Histopathology
, vol.63
, pp. 780-787
-
-
Morgado, J.M.1
Perbellini, O.2
Johnson, R.C.3
-
22
-
-
77955642537
-
Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives
-
Arock M, Valent P. Pathogenesis, classification and treatment of mastocytosis: state of the art in 2010 and future perspectives. Expert Rev Hematol 2010; 3(4): 497-516.
-
(2010)
Expert Rev Hematol
, vol.3
, Issue.4
, pp. 497-516
-
-
Arock, M.1
Valent, P.2
-
23
-
-
79955998389
-
A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib
-
Mital A, Piskorz A, Lewandowski K et al. A case of mast cell leukaemia with exon 9 KIT mutation and good response to imatinib. Eur J Haematol 2011; 86(6): 531-535.
-
(2011)
Eur J Haematol
, vol.86
, Issue.6
, pp. 531-535
-
-
Mital, A.1
Piskorz, A.2
Lewandowski, K.3
-
24
-
-
84874430998
-
Mast cell leukaemia: c-KIT mutations are not always positive
-
Joris M, Georgin-Lavialle S, Chandesris MO et al. Mast cell leukaemia: c-KIT mutations are not always positive. Case Rep Hematol 2012; 2012: 517546.
-
(2012)
Case Rep Hematol
, vol.2012
, pp. 517546
-
-
Joris, M.1
Georgin-Lavialle, S.2
Chandesris, M.O.3
-
25
-
-
84862578484
-
Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor
-
Georgin-Lavialle S, Lhermitte L, Suarez F et al. Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitor. Eur J Haematol 2012; 89(1): 47-52.
-
(2012)
Eur J Haematol
, vol.89
, Issue.1
, pp. 47-52
-
-
Georgin-Lavialle, S.1
Lhermitte, L.2
Suarez, F.3
-
26
-
-
84862005479
-
Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor ß chain and KIT V654A
-
Spector MS, Iossifov I, Kritharis A et al. Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor ß chain and KIT V654A. Leukemia 2012; 26(6): 1422-1425.
-
(2012)
Leukemia
, vol.26
, Issue.6
, pp. 1422-1425
-
-
Spector, M.S.1
Iossifov, I.2
Kritharis, A.3
-
27
-
-
84872762495
-
Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression
-
Verstovsek S. Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression. Eur J Haematol 2013; 90(2): 89-98.
-
(2013)
Eur J Haematol
, vol.90
, Issue.2
, pp. 89-98
-
-
Verstovsek, S.1
-
28
-
-
0032104728
-
In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation
-
Beghini A, Cairoli R, Morra E et al. In vivo differentiation of mast cells from acute myeloid leukemia blasts carrying a novel activating ligand-independent C-kit mutation. Blood Cells Mol Dis. 1998; 24(2): 262-270.
-
(1998)
Blood Cells Mol Dis.
, vol.24
, Issue.2
, pp. 262-270
-
-
Beghini, A.1
Cairoli, R.2
Morra, E.3
-
29
-
-
27144506215
-
Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation
-
Gotlib J, Berubé C, Growney JD et al. Activity of the tyrosine kinase inhibitor PKC412 in a patient with mast cell leukemia with the D816V KIT mutation. Blood 2005; 106(8): 2865-2870.
-
(2005)
Blood
, vol.106
, Issue.8
, pp. 2865-2870
-
-
Gotlib, J.1
Berubé, C.2
Growney, J.D.3
-
30
-
-
84876130624
-
A case of systemic mastocytosis associated with acute myeloid leukemia terminating as aleukemic mast cell leukemia after allogeneic hematopoietic stem cell transplantation
-
Bae MH, Kim HK, Park CJ et al. A case of systemic mastocytosis associated with acute myeloid leukemia terminating as aleukemic mast cell leukemia after allogeneic hematopoietic stem cell transplantation. Ann Lab Med. 2013; 33(2): 125-129.
-
(2013)
Ann Lab Med.
, vol.33
, Issue.2
, pp. 125-129
-
-
Bae, M.H.1
Kim, H.K.2
Park, C.J.3
-
32
-
-
41449093588
-
Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens
-
Krauth MT, Födinger M, Rebuzzi L et al. Aggressive systemic mastocytosis with sarcoma-like growth in the skeleton, leukemic progression, and partial loss of mast cell differentiation antigens. Haematologica 2007; 92(12): e126-e129.
-
(2007)
Haematologica
, vol.92
, Issue.12
-
-
Krauth, M.T.1
Födinger, M.2
Rebuzzi, L.3
-
33
-
-
85047685367
-
Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells
-
Valent P, Samorapoompichit P, Sperr WR et al. Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells. Hematol J 2002; 3(2): 90-94.
-
(2002)
Hematol J
, vol.3
, Issue.2
, pp. 90-94
-
-
Valent, P.1
Samorapoompichit, P.2
Sperr, W.R.3
-
34
-
-
26444578394
-
Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation
-
Sperr WR, Drach J, Hauswirth AW et al. Myelomastocytic leukemia: evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation. Clin Cancer Res 2005; 11: 6787-6792.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 6787-6792
-
-
Sperr, W.R.1
Drach, J.2
Hauswirth, A.W.3
-
35
-
-
77955483681
-
Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge
-
Arredondo AR, Gotlib J, Shier L et al. Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: a diagnostic challenge. Am J Hematol 2010; 85(8): 600-606.
-
(2010)
Am J Hematol
, vol.85
, Issue.8
, pp. 600-606
-
-
Arredondo, A.R.1
Gotlib, J.2
Shier, L.3
-
36
-
-
0027997487
-
Kit ligand/mast cell growth factorindependent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis
-
Valent P, Spanblöchl E, Bankl HC et al. Kit ligand/mast cell growth factorindependent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis. Blood 1994; 84(12): 4322-4332.
-
(1994)
Blood
, vol.84
, Issue.12
, pp. 4322-4332
-
-
Valent, P.1
Spanblöchl, E.2
Bankl, H.C.3
-
37
-
-
0032890734
-
Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells
-
Wimazal F, Sperr WR, Horny HP et al. Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells. Am J Hematol 1999; 61(1): 66-77.
-
(1999)
Am J Hematol
, vol.61
, Issue.1
, pp. 66-77
-
-
Wimazal, F.1
Sperr, W.R.2
Horny, H.P.3
-
38
-
-
34249333084
-
Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria
-
Valent P, Akin C, Escribano L et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest 2007; 37(6): 435-453.
-
(2007)
Eur J Clin Invest
, vol.37
, Issue.6
, pp. 435-453
-
-
Valent, P.1
Akin, C.2
Escribano, L.3
-
39
-
-
12144286558
-
Spanish Network on Mastocytosis (REMA). Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA)
-
Escribano L, Diaz-Agustin B, López A et al. Spanish Network on Mastocytosis (REMA). Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA). Cytometry B Clin Cytom 2004; 58(1): 1-8.
-
(2004)
Cytometry B Clin Cytom
, vol.58
, Issue.1
, pp. 1-8
-
-
Escribano, L.1
Diaz-Agustin, B.2
López, A.3
-
40
-
-
67349145955
-
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
-
Tefferi A, Levine RL, Lim KH et al. Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates. Leukemia. 2009; 23(5): 900-904.
-
(2009)
Leukemia.
, vol.23
, Issue.5
, pp. 900-904
-
-
Tefferi, A.1
Levine, R.L.2
Lim, K.H.3
-
41
-
-
79952336888
-
Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis
-
Wilson TM, Maric I, Simakova O et al. Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis. Haematologica 2011; 96(3): 459-463.
-
(2011)
Haematologica
, vol.96
, Issue.3
, pp. 459-463
-
-
Wilson, T.M.1
Maric, I.2
Simakova, O.3
-
42
-
-
84887658376
-
Comprehensive mutational profiling in advanced systemic mastocytosis
-
Schwaab J, Schnittger S, Sotlar K et al. Comprehensive mutational profiling in advanced systemic mastocytosis. Blood 2013; 122(14): 2460-2466.
-
(2013)
Blood
, vol.122
, Issue.14
, pp. 2460-2466
-
-
Schwaab, J.1
Schnittger, S.2
Sotlar, K.3
-
43
-
-
0021804366
-
Bone marrow findings in systemic mastocytosis
-
Horny HP, Parwaresch MR, Lennert K. Bone marrow findings in systemic mastocytosis. Hum Pathol 1985; 16(8): 808-814.
-
(1985)
Hum Pathol
, vol.16
, Issue.8
, pp. 808-814
-
-
Horny, H.P.1
Parwaresch, M.R.2
Lennert, K.3
-
44
-
-
0031682307
-
Diagnostic value of immunostaining for tryptase in patients with mastocytosis
-
Horny HP, Sillaber C, Menke D et al. Diagnostic value of immunostaining for tryptase in patients with mastocytosis. Am J Surg Pathol 1998; 22(9): 1132-1140.
-
(1998)
Am J Surg Pathol
, vol.22
, Issue.9
, pp. 1132-1140
-
-
Horny, H.P.1
Sillaber, C.2
Menke, D.3
-
45
-
-
0034986344
-
Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings
-
Horny HP, Valent P. Diagnosis of mastocytosis: general histopathological aspects, morphological criteria, and immunohistochemical findings. Leuk Res 2001; 25(7): 543-551.
-
(2001)
Leuk Res
, vol.25
, Issue.7
, pp. 543-551
-
-
Horny, H.P.1
Valent, P.2
-
46
-
-
33644763309
-
The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers
-
Horny HP, Sotlar K, Stellmacher F et al. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol 2006; 59(3): 298-302.
-
(2006)
J Clin Pathol
, vol.59
, Issue.3
, pp. 298-302
-
-
Horny, H.P.1
Sotlar, K.2
Stellmacher, F.3
-
47
-
-
25844516537
-
Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia
-
Krokowski M, Sotlar K, Krauth MT et al. Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia. Am J Clin Pathol 2005; 124(4): 560-568.
-
(2005)
Am J Clin Pathol
, vol.124
, Issue.4
, pp. 560-568
-
-
Krokowski, M.1
Sotlar, K.2
Krauth, M.T.3
-
48
-
-
5044230101
-
CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens
-
Sotlar K, Horny HP, Simonitsch I et al. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol 2004; 28(10): 1319-1325.
-
(2004)
Am J Surg Pathol
, vol.28
, Issue.10
, pp. 1319-1325
-
-
Sotlar, K.1
Horny, H.P.2
Simonitsch, I.3
-
49
-
-
0034987361
-
Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L)
-
Jordan JH, Walchshofer S, Jurecka W et al. Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: evidence for expression of CD2, CD117/Kit, and bcl-x(L). Hum Pathol 2001; 32(5): 545-552.
-
(2001)
Hum Pathol
, vol.32
, Issue.5
, pp. 545-552
-
-
Jordan, J.H.1
Walchshofer, S.2
Jurecka, W.3
-
50
-
-
0037317839
-
Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study
-
Horny HP, Greschniok A, Jordan JH et al. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study. J Clin Pathol 2003; 56(2): 103-106.
-
(2003)
J Clin Pathol
, vol.56
, Issue.2
, pp. 103-106
-
-
Horny, H.P.1
Greschniok, A.2
Jordan, J.H.3
-
51
-
-
84901294850
-
FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H
-
Valent P, Blatt K, Eisenwort G et al. FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H. Leuk Res Reports 2014; 3: 8-13.
-
(2014)
Leuk Res Reports
, vol.3
, pp. 8-13
-
-
Valent, P.1
Blatt, K.2
Eisenwort, G.3
-
52
-
-
84865645292
-
EuroFlow Consortium (EU-FP6, LSHBCT- 2006-018708). EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
-
van Dongen JJ, Lhermitte L, Böttcher S et al. EuroFlow Consortium (EU-FP6, LSHBCT- 2006-018708). EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia 2012; 26(9): 1908-1975.
-
(2012)
Leukemia
, vol.26
, Issue.9
, pp. 1908-1975
-
-
van Dongen, J.J.1
Lhermitte, L.2
Böttcher, S.3
-
53
-
-
0019461480
-
Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders
-
Prokocimer M, Polliack A. Increased bone marrow mast cells in preleukemic syndromes, acute leukemia, and lymphoproliferative disorders. Am J Clin Pathol 1981; 75(1): 34-38.
-
(1981)
Am J Clin Pathol
, vol.75
, Issue.1
, pp. 34-38
-
-
Prokocimer, M.1
Polliack, A.2
-
54
-
-
0034490248
-
Acute myeloblastic leukemia with differentiation to myeloblasts and mast cell blasts
-
Varma N, Varma S, Wilkins B. Acute myeloblastic leukemia with differentiation to myeloblasts and mast cell blasts. Br J Haematol 2000; 111(4): 991.
-
(2000)
Br J Haematol
, vol.111
, Issue.4
, pp. 991
-
-
Varma, N.1
Varma, S.2
Wilkins, B.3
-
55
-
-
84856184100
-
Mastocytosis and related disorders
-
Chiu A, Orazi A. Mastocytosis and related disorders. Semin Diagn Pathol 2012; 29 (1): 19-30.
-
(2012)
Semin Diagn Pathol
, vol.29
, Issue.1
, pp. 19-30
-
-
Chiu, A.1
Orazi, A.2
-
56
-
-
84878423607
-
International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis
-
Gotlib J, Pardanani A, Akin C et al. International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis. Blood 2013; 121(13): 2393-2401.
-
(2013)
Blood
, vol.121
, Issue.13
, pp. 2393-2401
-
-
Gotlib, J.1
Pardanani, A.2
Akin, C.3
|